BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| low fodmap diet - Bifidobacterium lemurum |
👶
Effects of a low FODMAP diet on the colonic microbiome in irritable bowel syndrome: a systematic review with meta-analysis. The American journal of clinical nutrition (Am J Clin Nutr ) Vol: 116 Issue 4 Pages: 943-952 Pub: 2022 Oct 6 Epub: Authors So D , Loughman A , Staudacher HM , Html Article Publication |
| low fodmap diet - Bifidobacterium lemurum |
👶
Ketogenic and Low FODMAP Diet in Therapeutic Management of a Young Autistic Patient with Epilepsy and Dysmetabolism Poorly Responsive to Therapies: Clinical Response and Effects of Intestinal Microbiota. International journal of molecular sciences (Int J Mol Sci ) Vol: 23 Issue 15 Pages: Pub: 2022 Aug 8 Epub: 2022 Aug 8 Authors Bertuccioli A , Cardinali M , Di Pierro F , Zonzini GB , Matera MR , Html Article Publication |
| low fodmap diet - Bifidobacterium lemurum |
👶
Randomised clinical trial: effect of low-FODMAP rye bread versus regular rye bread on the intestinal microbiota of irritable bowel syndrome patients: association with individual symptom variation. BMC nutrition (BMC Nutr ) Vol: 5 Issue Pages: 12 Pub: 2019 Epub: 2019 Mar 6 Authors Laatikainen R , Jalanka J , Loponen J , Hongisto SM , Hillilä M , Koskenpato J , Korpela R , Salonen A , Html Article Publication |
| low fodmap diet - Bifidobacterium lemurum |
👶
Gut microbiota associations with diet in irritable bowel syndrome and the effect of low FODMAP diet and probiotics. Clinical nutrition (Edinburgh, Scotland) (Clin Nutr ) Vol: 40 Issue 4 Pages: 1861-1870 Pub: 2021 Apr Epub: 2020 Oct 23 Authors Staudacher HM , Scholz M , Lomer MC , Ralph FS , Irving PM , Lindsay JO , Fava F , Tuohy K , Whelan K , Publication |
| low fodmap diet - Bifidobacterium lemurum |
👶
Long-term personalized low FODMAP diet improves symptoms and maintains luminal Bifidobacteria abundance in irritable bowel syndrome. Neurogastroenterology and motility (Neurogastroenterol Motil ) Vol: 34 Issue 4 Pages: e14241 Pub: 2022 Apr Epub: 2021 Aug 24 Authors Staudacher HM , Rossi M , Kaminski T , Dimidi E , Ralph FSE , Wilson B , Martin LD , Louis P , Lomer MCE , Irving PM , Whelan K , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
